Notice names this product. SUN PHARMACEUTICAL INDUSTRIES’s Carbamazepine Tablets is named in FDA Class II recall D-0770-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing Identifying details: Lot # AD94033, Exp Date: 5/31/2028.. Units affected: 1968 Bottles (1000Tablets/Bottle). Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
Company / brand: SUN PHARMACEUTICAL INDUSTRIES recalls
Affected product: Carbamazepine Tablets recall status
Official ID D-0770-2026 · Official record ↗
See all SUN PHARMACEUTICAL INDUSTRIES recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.